行情

CTSO

CTSO

Cytosorbents
NASDAQ

实时行情|Nasdaq Last Sale

5.49
+0.18
+3.39%
盘后: 5.49 0 0.00% 16:00 09/13 EDT
开盘
5.41
昨收
5.31
最高
5.55
最低
5.26
成交量
10.99万
成交额
--
52周最高
13.95
52周最低
3.680
市值
1.77亿
市盈率(TTM)
-10.3702
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CTSO 新闻

  • 沪指高开震荡 沙特石油设施遇袭、油价一度跳升20%
  • 新浪财经.34分钟前
  • 网易的“中台”往事
  • 钛媒体.1小时前
  • 分析师:沙特石油遇袭重创供应 油价100美元或重现
  • 新浪财经综合.2小时前
  • iPhone11发布意味着电子行业行情已结束?
  • 第一财经.2小时前

更多

所属板块

先进医疗设备和技术
-0.04%
医疗设备和用品
-0.35%

热门股票

名称
价格
涨跌幅

CTSO 简况

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.
展开

Webull提供Cytosorbents Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。